Published in PLoS One on March 27, 2017
Liver Adiposity and Metabolic Profile in Individuals with Chronic Spinal Cord Injury. Biomed Res Int (2017) 0.75
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest (2003) 32.01
Brown adipose tissue: function and physiological significance. Physiol Rev (2004) 23.00
Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care (1998) 8.29
Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell (2000) 7.26
International standards for neurological classification of spinal cord injury (revised 2011). J Spinal Cord Med (2011) 6.85
Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med (2006) 4.91
Pathophysiology of human visceral obesity: an update. Physiol Rev (2013) 4.41
Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest (1991) 3.49
A prospective assessment of mortality in chronic spinal cord injury. Spinal Cord (2005) 2.96
Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res (2009) 2.57
Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin Lab (2002) 2.40
HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin Chem (2011) 2.33
Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity (Silver Spring) (2012) 2.25
Factors influencing body composition in persons with spinal cord injury: a cross-sectional study. J Appl Physiol (1985) (2003) 2.23
Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem Soc Trans (2003) 2.11
Disorders of carbohydrate and lipid metabolism in veterans with paraplegia or quadriplegia: a model of premature aging. Metabolism (1994) 1.82
Effect of beta blockers on blood lipid profile. Am Heart J (1985) 1.79
Carbohydrate and lipid metabolism in chronic spinal cord injury. J Spinal Cord Med (2001) 1.74
Body composition and resting energy expenditure in long term spinal cord injury. Paraplegia (1990) 1.67
Spinal cord injury and type 2 diabetes: results from a population health survey. Neurology (2013) 1.62
Causes and costs of spinal cord injury in the United States. Spinal Cord (1997) 1.53
Visceral adipose tissue and the ratio of visceral to subcutaneous adipose tissue are greater in adults with than in those without spinal cord injury, despite matching waist circumferences. Am J Clin Nutr (2008) 1.50
Release of free fatty acids from subcutaneous adipose tissue in dogs following sympathetic nerve stimulation. Acta Physiol Scand (1967) 1.47
Soft tissue body composition differences in monozygotic twins discordant for spinal cord injury. J Appl Physiol (1985) (2000) 1.43
International standards to document remaining autonomic function after spinal cord injury. J Spinal Cord Med (2012) 1.43
Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens (2004) 1.38
Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord (2013) 1.35
Insulin in blood and insulin antibodies. Am J Med (1966) 1.34
The effect of residual neurological deficit on oral glucose tolerance in persons with chronic spinal cord injury. Spinal Cord (1999) 1.32
Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis. Diabetes Care (1991) 1.31
Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest (1994) 1.28
Plasma catecholamines, plasma renin activity and plasma aldosterone in tetraplegic man, horizontal and tilted. Clin Sci Mol Med (1975) 1.26
Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J (2001) 1.23
Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature. Diabetes Obes Metab (2005) 1.22
Lipoprotein lipase in diabetes. Diabetes Metab Rev (1987) 1.19
Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio. Eur J Clin Nutr (2009) 1.14
Lipolysis in human adipocytes, effects of cell size, age and of regional differences. Horm Metab Res Suppl (1988) 1.13
Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin-resistant state. Diabetes Care (1996) 1.10
Impaired skeletal muscle beta-adrenergic activation and lipolysis are associated with whole-body insulin resistance in rats bred for low intrinsic exercise capacity. Endocrinology (2009) 1.09
Central adiposity associations to carbohydrate and lipid metabolism in individuals with complete motor spinal cord injury. Metabolism (2010) 1.07
Not all fat is alike. Lancet (1998) 1.06
Increased cardiovascular disease risk in Swedish persons with paraplegia: The Stockholm spinal cord injury study. J Rehabil Med (2010) 1.02
EFFECT OF TILTING ON THE CARDIOVASCULAR RESPONSES AND PLASMA CATECHOLAMINE LEVELS IN SPINAL MAN. Paraplegia (1963) 0.98
The complex immunological and inflammatory network of adipose tissue in obesity. Mol Nutr Food Res (2015) 0.94
Influence of motor complete spinal cord injury on visceral and subcutaneous adipose tissue measured by multi-axial magnetic resonance imaging. J Spinal Cord Med (2011) 0.90
Visceral fat resection in humans: effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers. Obesity (Silver Spring) (2013) 0.89
ATP synthesis and storage. Purinergic Signal (2012) 0.89
Suppression of VLDL associated triacylglycerol secretion by both alpha- and beta-adrenoceptor agonists in isolated rat hepatocytes. Eur J Pharmacol (2006) 0.89
Serum lipid concentrations among persons with spinal cord injury - a systematic review and meta-analysis of the literature. Atherosclerosis (2013) 0.87
Innervation of the liver and glucoregulation: roles of the hypothalamus and autonomic nerves. Nutrition (1996) 0.86
Alpha-adrenergic suppression of very-low-density-lipoprotein triacylglycerol secretion by isolated rat hepatocytes. Biochem J (1988) 0.84
Hepatic denervation impairs the assembly and secretion of VLDL-TAG. Cell Biochem Funct (2008) 0.84
Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes (1987) 0.84
Increased risk of acute coronary syndrome after spinal cord injury: a nationwide 10-year follow-up cohort study. Int J Cardiol (2013) 0.83
The catecholamine content of the peripheral plasma in human subjects with complete transverse lesions of the spinal cord. J Physiol (1960) 0.82
Circulating fatty acids, non-high density lipoprotein cholesterol, and insulin-infused fat oxidation acutely influence whole body insulin sensitivity in nondiabetic men. J Clin Endocrinol Metab (2004) 0.82
High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL. J Clin Endocrinol Metab (1987) 0.82
Noradrenaline and ATP decrease the secretion of triglyceride and apoprotein B from perfused rat liver. Pflugers Arch (1998) 0.81
In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus. J Clin Endocrinol Metab (2001) 0.81
Liver denervation affects hepatocyte mitochondrial fatty acid transport capacity. Cell Biochem Funct (2003) 0.80
Role of hepatic, intrahepatic and hepatoenteral nerves in the regulation of carbohydrate metabolism and hemodynamics of the liver and intestine. Hepatogastroenterology (1999) 0.79
Visceral adiposity in persons with chronic spinal cord injury determined by dual energy X-ray absorptiometry. Obesity (Silver Spring) (2015) 0.77
Lipid metabolism: implications of alpha 1-blockade. J Clin Pharmacol (1993) 0.76